A., Masheb, R
Poor lifestyle choices may result in some or all of the weight regained
At this stage, retatrutide remains an investigational therapy
Miriyala S, Thippakorn C, Chaiswing L, Xu Y, Noel T, Tovmasyan A, et al
Abdominal injections tend to provide the most consistent and slightly faster absorption
This trend extends not only to injectable incretin-based agents and oral THR- receptor agonists, but also to emerging investigational classes that are gaining momentum, such as injectable long-acting fibroblast growth factor 21 (FGF21) analogues (e.g., efruxifermin ) and oral pan-peroxisome proliferator-activated receptor (PPAR) agonists (e.g., lanifibranor )